SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis

SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis

IntroductionSGLT2 inhibitors (SGLT2Is) have demonstrated cardioprotective and nephroprotective effects in patients with and without diabetes. Recent studies suggest that SGLT2Is may reduce the risk of contrast-induced nephropathy (CIN) in patients with diabetes undergoing coronary arteriography (CAG...

Full description

Bibliographic Details
Main Authors: Edinson Dante Meregildo-Rodriguez, Martha Genara Asmat-Rubio, Gustavo Adolfo Vásquez-Tirado
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Subjects:
sodium-glucose transporter 2 inhibitors
SGLT2 inhibitors
acute kidney injury
contrast-induced nephropathy
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1307715/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1307715/full

Similar Items